Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | |
| Cash Flows From Operating Activities | |
| Net Income | -256 |
| Depreciation Amortization | 2 |
| Other Working Capital | -36 |
| Operating Cash Flow | $-289 |
| Cash Flows From Investing Activities | |
| PPE Investments | -3 |
| Other Investing Activity | 197 |
| Investing Cash Flow | $194 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 182 |
| Financing Cash Flow | $182 |
| End Cash Position | 87 |
| Net Cash Flow | $87 |
| Free Cash Flow | |
| Operating Cash Flow | -289 |
| Free Cash Flow | -289 |